Antengene Reports First Profit as Pipeline Advances
Shanghai and Hong Kong, PRC, August 24, 2026 Antengene Corporation Limited has reported its first-ever profitable period, alongside continued...
FDA 510k
Advertisement
Henlius Reports 2026 Interim Results, Global Growth Advances
Shanghai, China,August 20, 2026 Henlius announced its 2026 interim results, highlighting continued financial growth, expanding global commercialization, and progress...
Aqua Medical Advances PIMA Trial for Type 2 Diabetes
PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...
Resivant Medical Advances Cutiva PLUS in First Human Use
AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutiva™...
Kandu Reports Positive IpsiHand BCI Stroke Trial Results
VAN NUYS, Calif., August 18, 2026 Kandu, Inc. announced the publication of results from BCI-REHAB, the first randomized controlled...
Advertisements
Vesalio Advances pVasc NET with FDA 510(k) Clearance
Dallas, Texas, August 13, 2026 Vesalio announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
Atrium Therapeutics Earns $15M BMS Milestone Payment
San Diego, California, August 13, 2026 Atrium Therapeutics, Inc. announced that it has earned a $15 million milestone payment...
Nitinotes Expands U.S. Obesity Trial at Weill Cornell Center
CAESAREA, Israel, August 13, 2026 Nitinotes Ltd., a medical device company developing automated endoluminal suturing technologies for obesity treatment,...
Galvanize Therapeutics Begins Commercial Aliya EX Procedures
Redwood City, California, August,11, 2026 Galvanize Therapeutics, Inc. has announced the completion of the first commercial procedures using its...
Evotec Expands AI Drug Discovery with Odyssey Partnership
Hamburg, Germany, August 8, 2026 Evotec SE has entered a strategic AI-enabled research and development collaboration with Odyssey Therapeutics...
Advertisement
